Series B - Walden Biosciences
Investment Firm
Overview
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Announced Date
Oct 01, 2023
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Walden Biosciences raised an undisclosed amount on 2023-10-01 in Series B
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 06, 2020 |  Series A - Walden Biosciences | 3 | - | 51.0M |
| Oct 01, 2023 | Series B - Walden Biosciences | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.